tiprankstipranks
Miji International Holdings Limited (HK:1715)
:1715
Hong Kong Market
Want to see HK:1715 full AI Analyst Report?

Miji International Holdings Limited (1715) AI Stock Analysis

0 Followers

Top Page

HK:1715

Miji International Holdings Limited

(1715)

Select Model
Select Model
Select Model
Neutral 45 (OpenAI - 5.2)
Rating:45Neutral
Price Target:
HK$0.49
▼(-0.41% Downside)
Action:Reiterated
Date:05/13/26
The score is primarily pressured by very weak financial performance (declining revenue, large losses, and ongoing cash burn), only partly offset by improving leverage and reduced cash outflow versus the prior year. Technicals are mixed/neutral with modest longer-term support, while valuation is constrained by negative earnings and no dividend yield data.
Positive Factors
Improved leverage
Debt-to-equity moving from ~1.44 to ~0.79 materially reduces financial strain and short-term refinancing pressure. This structural deleveraging improves solvency and gives management more flexibility to execute restructuring or invest selectively, increasing runway over the coming months.
Negative Factors
Deep sustained losses
Persistent, deep losses (net margin around -75% in 2025) indicate the core business is currently unprofitable. Continued negative earnings erode equity, limit reinvestment capacity, and force dependence on external financing or asset disposals to fund operations if structural profitability is not restored.
Read all positive and negative factors
Positive Factors
Negative Factors
Improved leverage
Debt-to-equity moving from ~1.44 to ~0.79 materially reduces financial strain and short-term refinancing pressure. This structural deleveraging improves solvency and gives management more flexibility to execute restructuring or invest selectively, increasing runway over the coming months.
Read all positive factors

Miji International Holdings Limited (1715) vs. iShares MSCI Hong Kong ETF (EWH)

Miji International Holdings Limited Business Overview & Revenue Model

Company Description
AI Health Technology Limited, an investment holding company, engages in the research and development, manufacturing, and trading of kitchen appliances primarily in the People's Republic of China. It provides radiant and induction hobs and stoves, ...

Miji International Holdings Limited Financial Statement Overview

Summary
Overall financial quality is weak: sustained losses, a sharp 2025 revenue decline (-22.9% YoY), very thin gross margin (~9%) and deeply negative net margin (~-75%). Cash flow remains negative in 2025 (FCF about -12.5M), though improved versus 2024, and leverage improved (debt-to-equity ~0.79 vs ~1.44) but returns are still deeply negative (ROE ~-58.9%).
Income Statement
12
Very Negative
Balance Sheet
38
Negative
Cash Flow
22
Negative
BreakdownDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue47.40M91.89M84.37M88.19M143.87M
Gross Profit4.26M6.49M21.22M38.49M65.27M
EBITDA-29.35M-28.31M-36.05M-30.94M-35.40M
Net Income-35.56M-35.85M-49.32M-43.21M-44.35M
Balance Sheet
Total Assets146.75M137.47M165.74M193.80M190.72M
Cash, Cash Equivalents and Short-Term Investments27.09M2.30M33.95M11.36M32.35M
Total Debt46.22M60.74M71.40M79.92M32.92M
Total Liabilities87.06M95.08M107.53M113.90M66.58M
Stockholders Equity58.83M42.06M58.21M80.36M124.27M
Cash Flow
Free Cash Flow-12.47M-35.37M13.80M-76.70M-13.24M
Operating Cash Flow-12.47M-35.21M14.42M-75.93M-11.02M
Investing Cash Flow0.00-101.00K-2.00K15.03M6.67M
Financing Cash Flow36.67M3.63M8.13M39.30M-10.74M

Miji International Holdings Limited Technical Analysis

Technical Analysis Sentiment
Negative
Last Price0.49
Price Trends
50DMA
0.50
Negative
100DMA
0.48
Positive
200DMA
0.44
Positive
Market Momentum
MACD
>-0.01
Positive
RSI
42.71
Neutral
STOCH
66.35
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:1715, the sentiment is Negative. The current price of 0.49 is below the 20-day moving average (MA) of 0.52, below the 50-day MA of 0.50, and above the 200-day MA of 0.44, indicating a neutral trend. The MACD of >-0.01 indicates Positive momentum. The RSI at 42.71 is Neutral, neither overbought nor oversold. The STOCH value of 66.35 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HK:1715.

Miji International Holdings Limited Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
81
Outperform
HK$701.42B11.0519.76%5.00%9.21%4.23%
71
Outperform
HK$451.19M6.20%12.90%0.71%2.66%
68
Neutral
HK$213.24B9.1915.65%5.20%2.10%-0.45%
61
Neutral
$18.38B12.79-2.54%3.03%1.52%-15.83%
60
Neutral
HK$488.10M5.164.84%7.24%-6.53%-49.31%
48
Neutral
HK$5.34B-35.42-4.81%4.06%-469.59%
45
Neutral
HK$176.77M-3.28-48.35%-48.40%59.08%
* Consumer Cyclical Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
HK:1715
Miji International Holdings Limited
0.49
0.23
88.46%
HK:1373
International Housewares Retail Co
0.69
-0.18
-20.42%
HK:0229
Raymond Industrial Limited
0.90
0.08
9.76%
HK:1691
JS Global Lifestyle Company Limited
1.56
-0.44
-22.00%
HK:6690
Haier Smart Home Co., Ltd. Class H
20.40
-2.18
-9.65%
HK:0300
Midea Group Co. Ltd. Class H
90.65
12.80
16.44%

Miji International Holdings Limited Corporate Events

AI Health Technology Overhauls Charter to Meet HKEX Paperless Regime
Apr 27, 2026
AI Health Technology Limited plans to overhaul its constitutional documents to align with updated regulatory standards in Hong Kong, including requirements tied to the Stock Exchange’s paperless listing framework and the move toward uncertif...
AI Health Technology Revamps Share Option Scheme to Meet Updated HK Listing Rules
Apr 21, 2026
AI Health Technology Limited plans to terminate its existing share option scheme, adopted in 2018, and replace it with a new 2026 Share Option Scheme, subject to shareholder approval at the upcoming annual general meeting. The company currently ha...
AI Health Technology Posts Steep Revenue Drop and Sustained Loss for 2025
Mar 31, 2026
AI Health Technology Limited reported a sharp decline in revenue to RMB47.4 million for the year ended 31 December 2025, down from RMB91.9 million a year earlier, while gross profit fell to RMB4.3 million but the gross margin improved to 9.0% from...
AI Health Technology Sets Board Meeting to Approve 2025 Results and Consider Dividend
Mar 13, 2026
AI Health Technology Limited has scheduled a board meeting for 31 March 2026 to approve the audited annual results for the year ended 31 December 2025. The board will also consider the recommendation of a final dividend, a decision that could affe...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: May 13, 2026